201
Participants
Start Date
September 13, 2017
Primary Completion Date
December 16, 2022
Study Completion Date
December 16, 2022
Other: Assessments
Administered as specified in the treatment arm.
Research Site, New York
Research Site, Miami
Research Site, Madison
Research Site, Dallas
Research Site, Houston
Research Site, Salt Lake City
Research Site, Phoenix
Research Site, Los Angeles
Research Site, San Francisco
Research Site, Portland
Research Site, Montreal
Research Site, Vancouver
Research Site, Helsinki
Research Site, Montpellier
Research Site, Bonn
Research Site, Tübingen
Research Site, Leiden
Research Site, Nijmegen
Research Site, Leeds
Research Site, Manchester
Research Site, Oxford
Research Site, Southampton
NightstaRx Ltd, a Biogen Company
OTHER